The Concept, Characteristics, and Classification of New Synthetic Drugs
Keywords:
Synthetic drugs, new psychoactive substances, drug classificationAbstract
This article investigates the growing phenomenon of new synthetic drugs (NSDs), commonly known as new psychoactive substances (NPS), by examining their conceptual foundations, distinguishing characteristics, and comprehensive classification. Emphasis is placed on their legal implications, chemical evolution, social impact, and challenges faced by law enforcement and public health systems. The research also explores international responses and Uzbekistan’s legislative stance on synthetic narcotics. Drawing upon a comparative legal and scientific methodology, this article provides an interdisciplinary perspective that combines pharmacology, criminology, and international law to offer policy recommendations and preventive frameworks.
References
1. EMCDDA. (2023). New Psychoactive Substances in Europe: Legislation and Control. Retrieved from https://www.emcdda.europa.eu
2. United Nations Office on Drugs and Crime. (2023). World Drug Report. Retrieved from https://www.unodc.org/unodc/en/data-and-analysis/wdr.html
3. World Health Organization. (2022). Expert Committee on Drug Dependence: Forty-fourth report. Geneva: WHO Technical Report Series.
4. U.S. Drug Enforcement Administration. (2023). Synthetic Drugs Overview. Retrieved from https://www.dea.gov/factsheets/synthetic-drugs
5. Ministry of Internal Affairs of the Republic of Uzbekistan. (2024). National Report on Drug Situation.
6. Interpol. (2023). Darknet and Synthetic Drugs. Retrieved from https://www.interpol.int/en/Crimes/Drugs-and-organized-crime
7. Reuter, P., & Pardo, B. (2017). Can New Psychoactive Substances Be Regulated Effectively? Addiction, 112(1), 25–31. https://doi.org/10.1111/add.13408
8. Rhumorbarbe, D., et al. (2020). The Highs and Lows of NPS Forensics. Drug Testing and Analysis, 12(5), 631–644. https://doi.org/10.1002/dta.2751
9. Degenhardt, L., et al. (2021). Global Patterns of Synthetic Drug Use. The Lancet Psychiatry, 8(2), 93–105. https://doi.org/10.1016/S2215-0366(20)30421-3
